Eslicarbazepine
Eslicarbazepine acetate (Stedesa) is a voltage-gated sodium channel blocker approved as an adjunctive treatment for partial-onset seizures in adults. It is widely used in neuroscience research for in vitro electrophysiology studies and in vivo models of epilepsy to investigate its anticonvulsant mechanisms.
Product Specifications
CAS Number
104746-04-5
Product Name Alternative
Stedesa, SodiumChannel, Sodium Channel, Voltage-gated sodium channel, βSecretase, β-Secretase, inhibit, Pazzul, Inhibitor, Erelib, Eslicarbazepine, EC 810-248-9, BIA 2-194, Beta-secretase, BetaSecretase, bSecretase, b-Secretase
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.23% (May vary between batches)
Solubility
DMSO:12 mg/mL (47.19 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.87 mM)
Smiles
NC (=O) N1c2ccccc2C[C@H] (O) c2ccccc12
Molecular Formula
C15H14N2O2
Molecular Weight
254.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880035-500 1x 500 µL
Calgranulin B / MRP-8/-14 / MAC 387 / S100A8/A9 / Macrophage Ag (MAC387), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 